References
- Paoletti C, Cross S, Dat-xuong N, Lecointe P, Moisand A. Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L1210 leukemia. Chem-Biol Interact 1979; 25: 45–58
- Amiel J L, Droz J P, Benayed F, Turz T H, Rouesse J, Sancho-Garnier H, Paoletti C. Chimiothérapie des cancers de reins métastasés par le N2-méthyl-9-hydroxy-ellipticinium (NMHE). Nouv Presse Med 1981; 10: 1504
- Maftouh M, Meunier G, Dugue B, Monsarrat B, Meunier B, Rao R, Paoletti C. Metabolism of the antitumor drugs N2-methyl-9-hydroxyellipticinium acetate (NSC 264137) and N2-methyl-9-hydroxy ovalicinium acetate in rat: preliminary identification of biliary (O) glucuronide and 10 (S)-gluthathione conjugates. Xenobiotica 1983; 13: 303–310
- Paoletti C, Le Pecq J B, Dat-Xuong N, Juret P, Garnier H, Amiel J L, Rouesse J. Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium and 9-hydroxy-derivatives: preliminary clinical trials of 2-methyl-9-hydroxy-ellipticinium (NSC-264–137). Recent Results Cancer Res 1980; 74: 107–123
- Caille P, Mondesir J M, Droz J P, Kerbra P, Goodman A, Ducret J P, Theodore C, Spielmann M, Rouesse J, Amiel J L. Phase II study of ellipticinium in advanced renal cell carcinoma. Cancer Treat Rep 1985; 69: 901–902
- Arteaga C L, Kisner D L, Goodman A, Von Hoff D D. Ellipticinium a DNA intercalating agent with broad antitumor activity in a human tumor cloning system. Eur J Cancer Clin Oncol 1987; 23: 1621–1625
- Juret P, Heron J F, Couette J E, Delozier T, Le Talaer J Y. Hydroxy-9-methyl-2-ellipticinium for osseous metastases from breast cancer. Cancer Treat Rep 1982; 66: 1909–1916
- Rouesse J G, Lechevalier T, Caille P, Mondesir J M, Sancho-Garnier H, Maylevin E, Spielmann M, De Jager R, Amiel J L. Phase II study of ellipticinium in advanced breast cancer. Cancer Treat Rep 1985; 69: 707–708
- Ryckelynck J P, Heron J F, Juret P, Schneider P, Herlin P, De Raneiri I E, Hardouin A, Peny J, Le Talaer J Y. Renal toxicity of 9-hydroxy-2-methylellipticinium. Néphrologie 1984; 5: 59–63
- Raguenez-Viotte G, Dadoun G, Buchet P, Ducastelle T, Fillastre J P. Renal toxicity of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate in the Wistar rat. Arch Toxicol 1988; 61: 292–297
- Van Bac N, Moisand C H, Gouyette A, Muzard G, Dat-Xuong N, Le Pecq J B, Paoletti C. Metabolism and disposition studies of 9-hydroxy ellipticine and 2-methyl-9-hydroxyellipticinium acetate in animals. Cancer Treat Rep 1980; 64: 879–887
- Monsarrat B, Maftouh M, Meunier G, Bernadou J, Armand J P, Paoletti C. Oxidative biotransformation of the antitumor agent ellipticinium acetate. Structural characterization of its human and rat urinary metabolites. J Pharm Biomed Anal 1987; 5: 341–351
- Maftouh M, Amiar Y, Picard-Fraire C. Metabolism of the antitumor drugs N2-methyl-9-hydroxyellipticinium acetate in isolated rat kidney cells. Biochem Pharmacol 1985; 34: 427–428
- Dadoun C, Raguenez-Viotte G. Celiptium induced nephrotoxicity and lipid peroxidation in rat renal cortex. Cancer Chemother Pharmacol 1990; 27: 178–186
- Basuyau J P, Le Bihan G, Brunelle P H, Bourreille J, Bohuon C. Radioimmunoassay of antidiuretic hormone choice of a technic of extraction. Normal and pathological values. Ann Biol Clin 1980; 38: 123–128
- Greenwood F C, Hunter W M, Glover D S. The preparation of 131I-labeled human growth hormone of high specific radioactivity. Biochem J 1963; 89: 114–123
- Husain M K, Fernando N, Shapiro M, Kagan A, Glick S M. Radioimmunoassay of arginine vasopressin in human plasma. J Clin Endocrinol Metabl 1973; 37: 616–625
- Wallenstein S, Zucker C, Fleiss J. Some statistical methods useful in circulation research. Circ Res 1980; 47: 1–9
- Peterson O, Blantz R. Nephron model of nephrotoxic acute renal failure. Evidence for functional reduction in nephron filtration rate after tubular damage. (Abstract). Xth Int. Congress of Nephrology. London 1987; 481
- Bankir L, De Rouffignac C. Urinary concentrating ability: insights from comparative anatomy. Am J Physiol 1985; 219: R643–R666
- Forrest J N, Cohen A D, Torretti D, Himmelhoch J M, Epstein F H. On the mechanism of lithium-induced diabetes insipidus in man and rat. J Clin Invest 1974; 53: 1115–1123
- Jenner F A, MacNeil S. The effects of lithium ions on the antidiuretic action of vasopressin in the rat. Br J Pharmacol 1975; 55: 527–534
- Clifton G G, Pearce C, O'Neill W M, Wallin J D. Early polyuria in the rat following single dose cis-dichlorodiamine platinum (II). J Lab Clin Med 1982; 100: 659–670
- Safirstein R, Miller P, Dikman S, Lyman N, Shapiro C. Cisplatin nephrotoxicity in rats: defect in papillary hypertonicity. Am J Physiol 1981; 241: F175–F185